Serum predictive cytokine validation in Rheumatoid Arthritis to withdraw Orencia by using ultrasound analysis
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000032316
- Lead Sponsor
- Kita-Harima Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Current complication of malignant tumor 2) severe infection including active tuberculosis 3) ongoing or history of demyelinating disease 4) congestive heart disease 5) previous treatment with glucocorticoid, DMARDs and biologics
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The remission rate of DAS, SDAI, CDAI, Boolean, mHAQ and USIR at Week 24
- Secondary Outcome Measures
Name Time Method